Anti-idiotypic immunity as a potential regulator in myeloma and related diseases

Ann N Y Acad Sci. 1991 Dec 30:636:178-83. doi: 10.1111/j.1749-6632.1991.tb33449.x.

Abstract

In this paper some recent and partly preliminary results on anti-idiotypic immunity against clonal B cells in human monoclonal gammopathies are summarized. B cell lines producing antibodies to idiotypic determinants on autologous monoclonal immunoglobulin could be propagated after activation with Epstein-Barr virus of peripheral blood lymphocytes from patients with MGUS and MM clinical stage I but not from untreated persons with advanced MM. Blood T lymphocytes from patients with MGUS and Waldenström's macroglobulinemia were activated to DNA synthesis and production of interleukins by the autologous M protein. In another series of experiments T cell clones raised from patients with MM clinical stage I and MGUS bound F(ab')2 fragments of the autologous M protein and were stimulated to DNA synthesis by the idiotope-bearing protein. Control experiments demonstrated the specificity for idiotypic determinants. Ten of eleven clones were CD4-/CD8+. Finally, using a panel of 8 mAbs to alpha/beta V region epitopes, we noted a clonal expansion of CD4+ and CD8+ T cells in MGUS and MM patients.

Publication types

  • Review

MeSH terms

  • Animals
  • Antibodies, Anti-Idiotypic / immunology*
  • B-Lymphocytes / immunology
  • Clone Cells
  • Humans
  • Lymphocytes / immunology*
  • Multiple Myeloma / immunology*
  • T-Lymphocytes / immunology

Substances

  • Antibodies, Anti-Idiotypic